Enrolling by InvitationN/Aketamine

Observational Study of Ketamine Infusions for the Treatment of Chronic Pain

NCT ID

NCT05477004

Target Enrollment

100 participants

Start Date

2022-06-01

Est. Completion

2026-12-31

About This Study

This observational study will collect prospectively specified data on patient characteristics and clinically relevant outcomes in patients who receive a ketamine infusion at Stanford Pain Management Center for the treatment of chronic pain, with the goal of identifying treatment responders and relationships between patient characteristics and treatment response.

Conditions Studied

Chronic Pain

Interventions

•Ketamine

Eligibility

Age:18 Years - N/A

Healthy Volunteers:No

View full eligibility criteria

Inclusion Criteria:

* Has been seen at Stanford's Pain Management Center for a doctor's visit at least once.
* Is scheduled to undergo at least 1 ketamine infusion for the treatment of any chronic pain condition.
* Have a valid email address and consents to receiving surveys by email.
* Able to read, understand, and respond to English-language surveys on an electronic device such as a cell phone, tablet, or computer.
* Able to read, understand, and provide written, dated informed consent.

Exclusion Criteria:

* Has their ketamine infusion cancelled, which may occur before or after consenting to this study.

Study Locations (1)

Stanford University